Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
Main Authors: | Patricia Rijo, Constantinos M. Athanassopoulos, María Cecilia Carpinella |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1108252/full |
Similar Items
-
Natural products reverse cancer multidrug resistance
by: Jia-Yu Zou, et al.
Published: (2024-03-01) -
Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01) -
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
by: Alessia Catalano, et al.
Published: (2022-01-01) -
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01) -
Current Uses of Mushrooms in Cancer Treatment and Their Anticancer Mechanisms
by: Hye-Jin Park
Published: (2022-09-01)